• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经病理性疼痛:一种以患者为中心的疗效评估方法。

Neuropathic pain: A patient-centred approach to measuring outcomes.

机构信息

Endpoint Outcomes, Boston, MA, USA.

Astellas Pharma B.V., Leiden, Netherlands.

出版信息

Health Expect. 2018 Aug;21(4):774-786. doi: 10.1111/hex.12673. Epub 2018 Apr 15.

DOI:10.1111/hex.12673
PMID:29656511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6117483/
Abstract

BACKGROUND

Neuropathic pain (NP) is a complex, chronic pain state initiated by a primary lesion or dysfunction of the nervous system and presents as a variety of symptoms across multiple disease states.

OBJECTIVE

To develop a patient-centred conceptual model of symptoms and impacts in subjects with diabetic peripheral neuropathy (DPN) or post-herpetic neuralgia (PHN) that can inform the measurement strategy in clinical trials.

METHOD

Thirty subjects with DPN or PHN participated in in-person interviews which were performed until saturation was achieved. Transcripts were analysed in ATLAS.ti.

RESULTS

Interviews were completed with DPN subjects (United States, n = 10; Japan, n = 10) and PHN subjects (United States, n = 5; Japan, n = 5). Numbness and tingling were frequently reported symptoms in the DPN population while itchiness and hypersensitivity were predominant in PHN. Both populations experienced burning and ache/soreness with similar frequency. DPN subjects experienced pain primarily in their lower extremity (eg feet, ankles), while PHN subjects experienced pain primarily in the chest and back. Impacts reported by DPN subjects included difficulty walking, sleep disturbance and climbing stairs. Impacts in PHN subjects included sleep disturbance, avoidance of physical contact, being angry/frustrated and being sad/depressed. Overall, concepts in Japan were not qualitatively different from the United States. Conceptual models of NP were generated based on the concepts elicited.

CONCLUSIONS

This research highlights core concepts to measure from the patient's perspective. Moreover, it enables the assessment of existing measures, the possible modification of these measures, or if a new NP measure with improved sensitivity and responsiveness is merited.

摘要

背景

神经病理性疼痛(NP)是一种由神经系统的原发性损伤或功能障碍引发的复杂、慢性疼痛状态,表现为多种症状,涉及多种疾病状态。

目的

针对患有糖尿病周围神经病变(DPN)或带状疱疹后神经痛(PHN)的患者,开发一种以患者为中心的症状和影响概念模型,为临床试验中的测量策略提供信息。

方法

30 名 DPN 或 PHN 患者参与了面对面访谈,直到达到饱和状态。使用 ATLAS.ti 对转录本进行分析。

结果

DPN 患者(美国,n=10;日本,n=10)和 PHN 患者(美国,n=5;日本,n=5)完成了访谈。麻木和刺痛是 DPN 人群中经常报告的症状,而瘙痒和超敏是 PHN 的主要症状。两种人群都有相似频率的烧灼感和酸痛/疼痛。DPN 患者主要在下肢(如脚、脚踝)感到疼痛,而 PHN 患者主要在胸部和背部感到疼痛。DPN 患者报告的影响包括行走困难、睡眠障碍和爬楼梯。PHN 患者的影响包括睡眠障碍、避免身体接触、生气/沮丧和悲伤/沮丧。总体而言,日本的概念与美国没有本质上的不同。根据引出的概念生成了 NP 的概念模型。

结论

这项研究从患者的角度强调了需要测量的核心概念。此外,它还可以评估现有的测量方法,对这些方法进行可能的修改,或者是否需要开发一种新的具有更高敏感性和反应性的 NP 测量方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16c/6117483/e458aee68d90/HEX-21-774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16c/6117483/e458aee68d90/HEX-21-774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d16c/6117483/e458aee68d90/HEX-21-774-g001.jpg

相似文献

1
Neuropathic pain: A patient-centred approach to measuring outcomes.神经病理性疼痛:一种以患者为中心的疗效评估方法。
Health Expect. 2018 Aug;21(4):774-786. doi: 10.1111/hex.12673. Epub 2018 Apr 15.
2
Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.普瑞巴林治疗周围神经性疼痛:来自日本和西方的随机对照试验的安全性数据综述。
Drug Saf. 2012 Oct 1;35(10):793-806. doi: 10.2165/11632660-000000000-00000.
3
Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.预测普瑞巴林对伴有痛性糖尿病周围神经病和疱疹后神经痛的患者的疼痛反应的疗效与睡眠障碍的严重程度有关。
Pain Med. 2014 Apr;15(4):661-70. doi: 10.1111/pme.12310. Epub 2013 Dec 11.
4
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.5%利多卡因药用贴剂与普瑞巴林治疗带状疱疹后神经痛和糖尿病性多发性神经病的开放标签、非劣效性两阶段随机对照试验研究
Curr Med Res Opin. 2009 Jul;25(7):1663-76. doi: 10.1185/03007990903047880.
5
Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.普瑞巴林治疗糖尿病性周围神经病变和带状疱疹后神经痛相关神经性疼痛的成本效益:加拿大视角
Clin Ther. 2006 Nov;28(11):1922-34. doi: 10.1016/j.clinthera.2006.11.017.
6
Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.糖尿病性周围神经病和带状疱疹后神经痛患者日常睡眠干扰量表的信度、效度及反应度
J Pain Symptom Manage. 2008 Jul;36(1):54-68. doi: 10.1016/j.jpainsymman.2007.09.016. Epub 2008 Apr 14.
7
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.5%利多卡因( lignocaine )药用贴剂与普瑞巴林治疗带状疱疹后神经痛和糖尿病性多发性神经病患者的疗效及安全性比较:一项开放标签、两阶段适应性、随机对照试验的中期分析
Clin Drug Investig. 2009;29(4):231-41. doi: 10.2165/00044011-200929040-00002.
8
Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.普瑞巴林用于治疗神经性疼痛:为何有望对多种疼痛病症产生疗效。
Clin Drug Investig. 2016 Nov;36(11):877-888. doi: 10.1007/s40261-016-0423-x.
9
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.普瑞巴林与加巴喷丁治疗带状疱疹后神经痛和糖尿病性神经病变相关外周神经病理性疼痛的疗效比较:希腊医疗环境下的成本效益分析
BMC Neurol. 2013 Jun 4;13:56. doi: 10.1186/1471-2377-13-56.
10
Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.在患有痛性糖尿病周围神经病变或疱疹后神经痛的患者中,普瑞巴林治疗与疼痛缓解及患者功能/生活质量改善的关系。
Clin Ther. 2013 May;35(5):612-23. doi: 10.1016/j.clinthera.2013.03.008. Epub 2013 Mar 28.

引用本文的文献

1
Navigating Preclinical Models and Medications for Peripheral Neuropathy: A Review.外周神经病变的临床前模型与药物研究综述
Pharmaceuticals (Basel). 2024 Jul 31;17(8):1010. doi: 10.3390/ph17081010.
2
Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: A systematic review and meta-analysis.拉丁美洲和加勒比地区糖尿病周围神经病变的患病率和发病率:系统评价和荟萃分析。
PLoS One. 2021 May 13;16(5):e0251642. doi: 10.1371/journal.pone.0251642. eCollection 2021.
3
Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study.

本文引用的文献

1
Increasing Patient Involvement in Drug Development.提高患者在药物研发中的参与度。
Value Health. 2016 Sep-Oct;19(6):869-878. doi: 10.1016/j.jval.2016.04.009. Epub 2016 May 24.
2
Coronary Sinus Lead Removal: A Comparison between Active and Passive Fixation Leads.冠状静脉窦导线拔除:主动固定导线与被动固定导线的比较
PLoS One. 2016 Apr 27;11(4):e0153651. doi: 10.1371/journal.pone.0153651. eCollection 2016.
3
Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature.在欧洲,患有疼痛性糖尿病周围神经病变的患者承受着巨大的人文和经济负担:文献综述。
米罗加巴林用于日本肾功能损害及伴有糖尿病性周围神经病变或带状疱疹后神经痛的疼痛患者:一项III期开放标签14周研究。
J Pain Res. 2020 Jul 17;13:1811-1821. doi: 10.2147/JPR.S255345. eCollection 2020.
4
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review.普瑞巴林用于治疗疼痛性糖尿病神经病变:一项叙述性综述
Diabetes Ther. 2019 Feb;10(1):35-56. doi: 10.1007/s13300-018-0550-x. Epub 2018 Dec 18.
Diabetes Res Clin Pract. 2015 Aug;109(2):215-25. doi: 10.1016/j.diabres.2015.04.031. Epub 2015 May 6.
4
The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes.神经性疼痛和其他合并症对糖尿病患者生活质量的影响。
Health Qual Life Outcomes. 2014 Dec 3;12:171. doi: 10.1186/s12955-014-0171-7.
5
Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation.美国寻求治疗的成年人中与周围性和中枢性神经性疼痛相关的疾病负担:一项以患者为中心的评估。
Pain Med. 2014 Dec;15(12):2105-19. doi: 10.1111/pme.12502. Epub 2014 Jul 8.
6
Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study.50 岁及以上英国居民带状疱疹后神经痛负担:带状疱疹生活质量(ZQOL)研究结果。
Health Qual Life Outcomes. 2014 Jun 11;12:92. doi: 10.1186/1477-7525-12-92.
7
Clinical characteristics, patient-reported outcomes, and previous therapeutic management of patients with uncontrolled neuropathic pain referred to pain clinics.转诊至疼痛门诊的未控制的神经性疼痛患者的临床特征、患者报告的结局及既往治疗管理情况。
Pain Res Treat. 2014;2014:518716. doi: 10.1155/2014/518716. Epub 2014 May 5.
8
Neuropathic pain in the general population: a systematic review of epidemiological studies.普通人群中的神经性疼痛:流行病学研究的系统评价
Pain. 2014 Apr;155(4):654-662. doi: 10.1016/j.pain.2013.11.013. Epub 2013 Nov 26.
9
Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.在患有痛性糖尿病周围神经病变或疱疹后神经痛的患者中,普瑞巴林治疗与疼痛缓解及患者功能/生活质量改善的关系。
Clin Ther. 2013 May;35(5):612-23. doi: 10.1016/j.clinthera.2013.03.008. Epub 2013 Mar 28.
10
The burden associated with neuropathic pain in Western Europe.西欧神经性疼痛的负担。
J Med Econ. 2013;16(1):85-95. doi: 10.3111/13696998.2012.729548. Epub 2012 Oct 10.